Giselle A Baquero1, Javier E Banchs2, Shameer Ahmed1, Gerald V Naccarelli1, Jerry C Luck3. 1. Penn State Hershey Heart & Vascular Institute, Division of Cardiology, Department of Medicine, Penn State College of Medicine, Penn State University, Hershey, PA. 2. Texas A & M College of Medicine, Baylor Scott & White Health, Temple, TX. 3. Penn State Hershey Heart & Vascular Institute, Division of Cardiology, Department of Medicine, Penn State College of Medicine, Penn State University, Hershey, PA. Electronic address: jluck@hmc.psu.edu.
Abstract
IMPORTANCE: AliveCor ECG is an FDA approved ambulatory cardiac rhythm monitor that records a single channel (lead I) ECG rhythm strip using an iPhone. In the past few years, the use of smartphones and tablets with health related applications has significantly proliferated. OBJECTIVE: In this initial feasibility trial, we attempted to reproduce the 12 lead ECG using the bipolar arrangement of the AliveCor monitor coupled to smart phone technology. METHODS: We used the AliveCor heart monitor coupled with an iPhone cellular phone and the AliveECG application (APP) in 5 individuals. RESULTS: In our 5 individuals, recordings from both a standard 12 lead ECG and the AliveCor generated 12 lead ECG had the same interpretation. CONCLUSIONS: This study demonstrates the feasibility of creating a 12 lead ECG with a smart phone. The validity of the recordings would seem to suggest that this technology could become an important useful tool for clinical use. This new hand held smart phone 12 lead ECG recorder needs further development and validation.
IMPORTANCE: AliveCor ECG is an FDA approved ambulatory cardiac rhythm monitor that records a single channel (lead I) ECG rhythm strip using an iPhone. In the past few years, the use of smartphones and tablets with health related applications has significantly proliferated. OBJECTIVE: In this initial feasibility trial, we attempted to reproduce the 12 lead ECG using the bipolar arrangement of the AliveCor monitor coupled to smart phone technology. METHODS: We used the AliveCor heart monitor coupled with an iPhone cellular phone and the AliveECG application (APP) in 5 individuals. RESULTS: In our 5 individuals, recordings from both a standard 12 lead ECG and the AliveCor generated 12 lead ECG had the same interpretation. CONCLUSIONS: This study demonstrates the feasibility of creating a 12 lead ECG with a smart phone. The validity of the recordings would seem to suggest that this technology could become an important useful tool for clinical use. This new hand held smart phone 12 lead ECG recorder needs further development and validation.
Authors: Kathleen T Hickey; Angelo B Biviano; Hasan Garan; Robert R Sciacca; Teresa Riga; Kate Warren; Ashton P Frulla; Nicole R Hauser; Daniel Y Wang; William Whang Journal: J Atr Fibrillation Date: 2017-02-28